Patents by Inventor Robert J. Collier

Robert J. Collier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150196507
    Abstract: The present invention is a method for increasing serotonin activity in mammary glands such that involution of milk secretion of the same mammary glands occurs. The present invention further is a composition that can be implanted, or infused into the mammary glands to cause involution of milk secretion.
    Type: Application
    Filed: January 14, 2015
    Publication date: July 16, 2015
    Inventors: Nelson D. Horseman, Robert J. Collier, Aaron M. Marshall, Laura Hernandez Baumgard
  • Patent number: 9079952
    Abstract: The invention provides compositions and methods for delivering a bioactive moiety comprising at least one non-natural component into a cell cytosol of an eukaryotic cell. The bioactive moiety is linked to an A component of a bacterial toxin, a functional wild-type or modified fragment thereof, or an A component surrogate or mimetic. For delivery, the cell is contacted with the linked bioactive moiety and a corresponding B component of the bacterial toxin or a functional fragment thereof.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: July 14, 2015
    Assignee: President and Fellows of Harvard College
    Inventors: Robert J. Collier, Brad L. Pentelute
  • Patent number: 8987336
    Abstract: The present invention is a method for increasing serotonin activity in mammary glands such that involution of milk secretion of the same mammary glands occurs. The present invention further is a composition that can be implanted, or infused into the mammary glands to cause involution of milk secretion.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: March 24, 2015
    Assignee: Amelgo, LLC
    Inventors: Nelson D. Horseman, Robert J. Collier, Aaron M. Marshall, Laura Hernandez Baumgard
  • Publication number: 20140219926
    Abstract: A biodegradable iron oxide nanoparticle gel for hyperthermia treatment of cancer includes a polysaccharide-based carrier matrix and starch-coated iron oxide nanoparticles. The gel has sufficient deformability to integrate into a diffuse tumor site, adheres to tissue and has sufficient mechanical properties to remain in place during hyperthermia treatment. The gel releases iron oxide nanoparticles for uptake by cancerous cells at the tumor margin.
    Type: Application
    Filed: February 3, 2014
    Publication date: August 7, 2014
    Applicant: The Trustees Of Dartmouth College
    Inventors: Benjamin P. Cunkelman, Jennifer A. Tate, Alicia A. Petryk, P. Jack Hoopes, Robert J. Collier, Sara G. Thappa
  • Publication number: 20130336974
    Abstract: The invention provides compositions and methods for delivering a bioactive moiety comprising at least one non-natural component into a cell cytosol of an eukaryotic cell. The bioactive moiety is linked to an A component of a bacterial toxin, a functional wild-type or modified fragment thereof, or an A component surrogate or mimetic. For delivery, the cell is contacted with the linked bioactive moiety and a corresponding B component of the bacterial toxin or a functional fragment thereof.
    Type: Application
    Filed: January 10, 2012
    Publication date: December 19, 2013
    Applicant: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Robert J. Collier, Brad L. Pentelute
  • Patent number: 8133916
    Abstract: The present invention is a method for increasing serotonin activity in mammary glands such that involution of milk secretion of the same mammary glands occurs. The present invention further is a composition that can be implanted, or infused into the mammary glands to cause involution of milk secretion.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: March 13, 2012
    Assignee: Amelgo, LLC
    Inventors: Nelson D. Horseman, Robert J. Collier, Aaron M. Marshall, Laura Hernandez Baumgard
  • Publication number: 20080153819
    Abstract: The present invention provides methods for inhibiting increased vascular permeability and/or pathologic ocular angiogenesis and providing neuroprotection of the affected retina via administration of a combination of one or more molecules that potently inhibit select receptor tyrosine kinases (RTKs) or vascular endothelial growth factor (VEGF) and one or more neuroprotectants.
    Type: Application
    Filed: December 21, 2007
    Publication date: June 26, 2008
    Inventors: David P. Bingaman, Robert J. Collier, Robert A. Landers, Kristina L. Rhoades
  • Publication number: 20040116403
    Abstract: The use of SOD mimics, particularly Mn(III) porphyrin complexes, for the treatment of AMD, DR, and retinal edema is disclosed.
    Type: Application
    Filed: December 5, 2003
    Publication date: June 17, 2004
    Inventors: Peter G. Klimko, Robert J. Collier, Mark R. Hellberg
  • Publication number: 20040116402
    Abstract: The use of SOD mimics, particularly Mn(III) salen SOD mimics, for the treatment of AMD, DR, and retinal edema is disclosed.
    Type: Application
    Filed: December 5, 2003
    Publication date: June 17, 2004
    Inventors: Peter G. Klimko, Robert J. Collier, Mark R. Hellberg
  • Patent number: 5374523
    Abstract: An assay for determining the presence in bovine genetic material of a genetic marker located on the bovine somatotropin gene indicative of an inheritable trait of increased milk production is provided. The marker is a polymorphism in the gene encoding somatotropin at amino acid position 126 which results in two forms of somatotropin existing in bovine. The assay comprises analyzing a bovine to determine its genotype with respect to the somatotropin gene. Bovine with the desired marker can be selected for inclusion in breeding programs or for milking. The desired marker indicative of superior milk production is dependent upon the breed of cattle. Holstein cattle that are homozygous for the leucine forms of somatotropin are desired. Jersey cattle that are homozygous for the valine form of somatotropin are desired. A kit for performing the assay is also provided.
    Type: Grant
    Filed: August 10, 1992
    Date of Patent: December 20, 1994
    Assignee: Monsanto Company
    Inventors: Robert J. Collier, Scott D. Hauser, Gwen G. Krivi, Matthew C. Lucy
  • Patent number: 5182302
    Abstract: The growth of milk-producing mammary parenchyma in a mammal can be significantly enhanced by administering to the mammal by intramammary infusion a substance having a mitogenic effect on mammary epithelial cells in said mammal. Good growth enhancement can be achieved using very small quantities of such substances, and in relatively short periods of time.
    Type: Grant
    Filed: June 28, 1991
    Date of Patent: January 26, 1993
    Assignee: Monsanto Company
    Inventors: Robert J. Collier, Michael F. McGrath
  • Patent number: 5130300
    Abstract: The growth of milk-producing mammary parenchyma in a mammal can be significantly enhanced by administering to the mammal by intramammary infusion a substance having a mitogenic effect on mammary epithelial cells in said mammal. Good growth enhancement can be achieved using very small quantities of such substances, and in relatively short periods of time.
    Type: Grant
    Filed: March 14, 1990
    Date of Patent: July 14, 1992
    Assignee: Monsanto Company
    Inventors: Robert J. Collier, Michael F. McGrath
  • Patent number: 5130299
    Abstract: The growth of milk-producing mammary parenchyma in a mammal can be significantly enhanced by administering to the mammal by intramammary infusion a substance having a mitogenic effect on mammary epithelial cells in said mammal. Good growth enhancement can be achieved using very small quantities of such substances, and in relatively short periods of time.
    Type: Grant
    Filed: June 28, 1991
    Date of Patent: July 14, 1992
    Assignee: Monsanto Company
    Inventors: Robert J. Collier, Michael F. McGrath
  • Patent number: 5059586
    Abstract: The growth of milk-producing mammary parenchyma in a mammal can be significantly enhanced by administering to the mammal by intramammary infusion a substance having a mitogenic effect on mammary epithelial cells in said mammal. Good growth enhancement can be achieved using very small quantities of such substances, and in relatively short periods of time.
    Type: Grant
    Filed: September 2, 1987
    Date of Patent: October 22, 1991
    Assignee: Monsanto Company
    Inventors: Robert J. Collier, Michael F. McGrath
  • Patent number: 4393312
    Abstract: For a given resolution or address dimension, the pattern-writing speed of an electron beam exposure system is increased by utilizing a new mode of raster scanning. In the new mode, the writing spot dimensions of the electron beam are varied rapidly during the scan. In an electron column designed for variable-spot raster scanning, an illuminated aperture is demagnified to form the writing spot. By imaging a first aperture upon a second aperture and rapidly deflecting the image of the first aperture, the portion of the second aperture that is illuminated by the electron beam is altered. In that way, the spot size is selectively varied in a high-speed way during the raster scanning process.
    Type: Grant
    Filed: November 29, 1977
    Date of Patent: July 12, 1983
    Assignee: Bell Telephone Laboratories, Incorporated
    Inventors: Robert J. Collier, Michael G. R. Thomson
  • Patent number: 4167676
    Abstract: An attractive high-throughput technique for writing microcircuit patterns with a scanning electron spot of variable size is described in application Ser. No. 855,608, filed Nov. 29, 1977. In such an electron beam exposure system, two spaced-apart apertured mask plates with a deflector therebetween are included in the electron column of the system. As described herein, a third apertured mask plate and an associated deflector are serially added to the aforenoted components in the column. In this way, the throughput and other performance characteristics of such a system are significantly enhanced.
    Type: Grant
    Filed: February 21, 1978
    Date of Patent: September 11, 1979
    Assignee: Bell Telephone Laboratories, Incorporated
    Inventor: Robert J. Collier
  • Patent number: 4060620
    Abstract: The administration of reserpine to nonlactating dairy cattle produces a marked increase in circulating serum prolactin levels. The parenteral administration of reserpine to nonlactating cows which have been hormonally induced into lactation, as by the parenteral administration of an estrogen and progesterone, and dexamethasone, results in a substantial rise in milk production.
    Type: Grant
    Filed: May 17, 1976
    Date of Patent: November 29, 1977
    Assignee: University of Illinois Foundation
    Inventors: Dale E. Bauman, Robert J. Collier, Ray L. Hays